Elsevier Provides Free Clinical Reference Support for Japan Earthquake Relief Efforts
Tokyo, Japan, 25 March, 2011 – Elsevier, a world leader in health care and medical publishing and online solutions, today announced that following the devastating earthquake and tsunami that struck Japan on March 11, the company is providing free access to its primary online clinical reference tools – MD Consult and First Consult – to all IPs originating from Japan. Free access will be available through April, 2011. This effort is part of a new initiative to provide easily accessible focused resources in response to world events that present difficult medical challenges.
MD Consult is an authoritative combination of clinically relevant information to give medical professionals an answer to their clinical questions, stay abreast of recent developments, and educate patients, resulting in better patient care and improved outcomes. First Consult is Elsevier’s point-of-care content that is integrated within MD Consult and leverages evidence-based medical information to deliver answers that are trusted, quick, and accessible.
MD Consult has also added a recommended resource topic page for Radiation Sickness, which is linked from www.mdconsult.com.
If access to a desktop computer is problematic, MD Consult has a mobile version, and First Consult has an Phone/iPad app that provides offline access to First Consult’s content in areas that have limited or no internet connectivity.
Emergency Access Initiative
Elsevier is also providing free online access to medical information for healthcare professionals in Japan through the Emergency Access Initiative (EAI), a partnership of the National Library of Medicine and the Professional/Scholarly Publishing Division of the Association of American Publishers and other publishers. EAI provides temporary free access to full-text articles from major biomedicine titles to healthcare professionals, librarians and the public affected by disasters. The idea for EAI was proposed in the aftermath of 9/11, but its first real use was in response to last year's earthquake in Haiti.
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence, and ClinicalKey — and publishes nearly 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.
The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).Media Contact
Vice President, Global Corporate Relations